Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF

Sandra Sanders-van Wijk; Stefano Muzzarelli; Michael Neuhaus; Stephanie Kiencke; Micha Maeder; Werner Estlinbaum; Daniel Tobler; Kurt Mayer; Paul Erne; Matthias E. Pfisterer; Hans-Peter Brunner-La Rocca

doi:10.1093/eurjhf/hft079

Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF

Sandra Sanders-van Wijk^*, Stefano Muzzarelli, Michael Neuhaus, Stephanie Kiencke, Micha Maeder, Werner Estlinbaum, Daniel Tobler, Kurt Mayer, Paul Erne, Matthias E. Pfisterer, Hans-Peter Brunner-La Rocca

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	910-918
Journal	European journal of heart failure
Volume	15
Issue number	8
DOIs	https://doi.org/10.1093/eurjhf/hft079
Publication status	Published - Aug 2013

Keywords

Heart failure
Natriuretic peptide
Safety
Drug therapy
Ageing
Co-morbidities

Access to Document

10.1093/eurjhf/hft079

Cite this

Sanders-van Wijk, S., Muzzarelli, S., Neuhaus, M., Kiencke, S., Maeder, M., Estlinbaum, W., Tobler, D., Mayer, K., Erne, P., Pfisterer, M. E., & Brunner-La Rocca, H-P. (2013). Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF. European journal of heart failure, 15(8), 910-918. https://doi.org/10.1093/eurjhf/hft079

Sanders-van Wijk, Sandra ; Muzzarelli, Stefano ; Neuhaus, Michael ; Kiencke, Stephanie ; Maeder, Micha ; Estlinbaum, Werner ; Tobler, Daniel ; Mayer, Kurt ; Erne, Paul ; Pfisterer, Matthias E. ; Brunner-La Rocca, Hans-Peter. / Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF. In: European journal of heart failure. 2013 ; Vol. 15, No. 8. pp. 910-918.

@article{0f9d934ea4874ebd9bb1797dc1ad7aa0,

title = "Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF",

keywords = "Heart failure, Natriuretic peptide, Safety, Drug therapy, Ageing, Co-morbidities",

author = "{Sanders-van Wijk}, Sandra and Stefano Muzzarelli and Michael Neuhaus and Stephanie Kiencke and Micha Maeder and Werner Estlinbaum and Daniel Tobler and Kurt Mayer and Paul Erne and Pfisterer, {Matthias E.} and {Brunner-La Rocca}, Hans-Peter",

year = "2013",

month = aug,

doi = "10.1093/eurjhf/hft079",

language = "English",

volume = "15",

pages = "910--918",

journal = "European journal of heart failure",

issn = "1388-9842",

publisher = "Wiley",

number = "8",

}

Sanders-van Wijk, S, Muzzarelli, S, Neuhaus, M, Kiencke, S, Maeder, M, Estlinbaum, W, Tobler, D, Mayer, K, Erne, P, Pfisterer, ME & Brunner-La Rocca, H-P 2013, 'Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF', European journal of heart failure, vol. 15, no. 8, pp. 910-918. https://doi.org/10.1093/eurjhf/hft079

Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF. / Sanders-van Wijk, Sandra; Muzzarelli, Stefano; Neuhaus, Michael; Kiencke, Stephanie; Maeder, Micha; Estlinbaum, Werner; Tobler, Daniel; Mayer, Kurt; Erne, Paul; Pfisterer, Matthias E.; Brunner-La Rocca, Hans-Peter.

In: European journal of heart failure, Vol. 15, No. 8, 08.2013, p. 910-918.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF

AU - Sanders-van Wijk, Sandra

AU - Muzzarelli, Stefano

AU - Neuhaus, Michael

AU - Kiencke, Stephanie

AU - Maeder, Micha

AU - Estlinbaum, Werner

AU - Tobler, Daniel

AU - Mayer, Kurt

AU - Erne, Paul

AU - Pfisterer, Matthias E.

AU - Brunner-La Rocca, Hans-Peter

PY - 2013/8

Y1 - 2013/8

KW - Heart failure

KW - Natriuretic peptide

KW - Safety

KW - Drug therapy

KW - Ageing

KW - Co-morbidities

U2 - 10.1093/eurjhf/hft079

DO - 10.1093/eurjhf/hft079

M3 - Article

C2 - 23666681

VL - 15

SP - 910

EP - 918

JO - European journal of heart failure

JF - European journal of heart failure

SN - 1388-9842

IS - 8

ER -

Sanders-van Wijk S, Muzzarelli S, Neuhaus M, Kiencke S, Maeder M, Estlinbaum W et al. Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF. European journal of heart failure. 2013 Aug;15(8):910-918. https://doi.org/10.1093/eurjhf/hft079